166 related articles for article (PubMed ID: 29805248)
1. Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011-2014.
Harris AM; Isenhour C; Schillie S; Vellozzi C
Infect Dis Obstet Gynecol; 2018; 2018():4107329. PubMed ID: 29805248
[TBL] [Abstract][Full Text] [Related]
2. Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015-2020.
Pham TTH; Maria N; Cheng V; Nguyen B; Toy M; Hutton D; Conners EE; Nelson NP; Salomon JA; So S
Am J Prev Med; 2023 Jul; 65(1):52-59. PubMed ID: 36906494
[TBL] [Abstract][Full Text] [Related]
3. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
5. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Surface Antigen Testing Among Pregnant Women, United States 2014.
Kolasa MS; Tsai Y; Xu J; Fenlon N; Schillie S
Pediatr Infect Dis J; 2017 Jul; 36(7):e175-e180. PubMed ID: 28030527
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate.
Chang HL; Wen WH; Lee CN; Chiu YE; Liu CJ; Chang MH; Lin LH; Chen HL
J Viral Hepat; 2022 Feb; 29(2):107-114. PubMed ID: 34724288
[TBL] [Abstract][Full Text] [Related]
10. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Pregnant Women With Hepatitis B Virus Infection in 5 US Public Health Jurisdictions, 2008-2012.
Walker TY; Smith EA; Fenlon N; Lazaroff JE; Dusek C; Fineis P; Crowley SA; Benson R; Veselsky SL; Murphy TV
Public Health Rep; 2016 Sep; 131(5):685-694. PubMed ID: 28123209
[TBL] [Abstract][Full Text] [Related]
12. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
[TBL] [Abstract][Full Text] [Related]
14. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
[TBL] [Abstract][Full Text] [Related]
15. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
[No Abstract] [Full Text] [Related]
17. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
; Dionne-Odom J; Tita AT; Silverman NS
Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
[TBL] [Abstract][Full Text] [Related]
18. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China.
Cui F; Woodring J; Chan P; Xu F
Int J Epidemiol; 2018 Oct; 47(5):1529-1537. PubMed ID: 29757383
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy.
Zeng J; Zheng C; Li H
Medicine (Baltimore); 2019 Apr; 98(14):e15092. PubMed ID: 30946367
[TBL] [Abstract][Full Text] [Related]
20. Acceptance of antiviral treatment and enhanced service model for pregnant patients carrying hepatitis B.
Hui PW; Ng C; Cheung KW; Lai CL
Hong Kong Med J; 2020 Aug; 26(4):318-322. PubMed ID: 32801216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
